Company: Aduro Biotech Inc.

ADRO

Stock Code:

Enter Stock Code:

This report provides insider trading pattern and statistics for "Aduro Biotech Inc. (ADRO)" . Please read important descriptions at the bottom of this report.

Register Free Insider Trade Email Alert for "Aduro Biotech Inc. (ADRO)" !



 

Analysis & Screening

Chart Screening Tool

  Transaction Date

  Filing Date

Start Date:

Select Start Date

End Date:

Select End Date

Trading History Screening Tool

Transaction Code:

Ownership:

Share Class:

Trade Price From:

to

Transaction History From July 22nd, 2017 To August 22nd, 2017 (Max 50 Records Displayed)

Filing Date

Trade Date

 

Insider Name

Event Code

Ownership

Trade Information

Holding % Change

Aug 11/17

Aug 11/17

CxO Sell

Dubensky Thomas W.

Chief Scientific Officer

M

Direct ownership

Disposed -9,088 Stock Option (Right to Buy)

-6.71%

Aug 11/17

Aug 11/17

CxO Sell

Dubensky Thomas W.

Chief Scientific Officer

S

Direct ownership

Disposed -9,088 Common Stock at $11.17

-18.55%

Aug 11/17

Aug 11/17

CxO Buy

Dubensky Thomas W.

Chief Scientific Officer

M

Direct ownership

Acquired 9,088 Common Stock at $1.00

22.78%

Aug 11/17

Aug 10/17

CxO Sell

Dubensky Thomas W.

Chief Scientific Officer

M

Direct ownership

Disposed -40,912 Stock Option (Right to Buy)

-23.20%

Aug 11/17

Aug 10/17

CxO Sell

Dubensky Thomas W.

Chief Scientific Officer

S

Direct ownership

Disposed -40,912 Common Stock at $11.43

-50.63%

Aug 11/17

Aug 10/17

CxO Buy

Dubensky Thomas W.

Chief Scientific Officer

M

Direct ownership

Acquired 40,912 Common Stock at $1.00

102.54%

Aug 09/17

Aug 08/17

CxO Sell

SCHAFER GREGORY W

Chief Operating Officer

M

Direct ownership

Disposed -5,711 Stock Option (right to buy)

-2.63%

Aug 09/17

Aug 08/17

CxO Sell

SCHAFER GREGORY W

Chief Operating Officer

M

Direct ownership

Disposed -8,478 Stock Option (right to buy)

-5.66%

Aug 09/17

Aug 08/17

CxO Sell

SCHAFER GREGORY W

Chief Operating Officer

S

Direct ownership

Disposed -14,189 Common Stock at $12.16

-10.50%

Aug 09/17

Aug 08/17

CxO Buy

SCHAFER GREGORY W

Chief Operating Officer

M

Direct ownership

Acquired 5,711 Common Stock at $1.00

4.41%

Aug 09/17

Aug 08/17

CxO Buy

SCHAFER GREGORY W

Chief Operating Officer

M

Direct ownership

Acquired 8,478 Common Stock at $1.45

7.01%

Aug 09/17

Aug 07/17

CxO Sell

SCHAFER GREGORY W

Chief Operating Officer

M

Direct ownership

Disposed -12,900 Stock Option (right to buy)

-7.93%

Aug 09/17

Aug 07/17

First-Class Insider Sell

ISAACS STEPHEN T

President and CEO

S

Direct ownership

Disposed -40,000 Common Stock at $12.19

-27.77%

Aug 09/17

Aug 07/17

First-Class Insider Sell

ISAACS STEPHEN T

President and CEO

M

Direct ownership

Disposed -40,000 Stock Option (right to buy)

-16.05%

Aug 09/17

Aug 07/17

CxO Buy

SCHAFER GREGORY W

Chief Operating Officer

M

Direct ownership

Acquired 12,900 Common Stock at $1.45

10.66%

Aug 09/17

Aug 07/17

CxO Buy

SCHAFER GREGORY W

Chief Operating Officer

M

Direct ownership

Acquired 12,911 Common Stock at $1.00

9.64%

Aug 09/17

Aug 07/17

CxO Sell

SCHAFER GREGORY W

Chief Operating Officer

S

Direct ownership

Disposed -25,811 Common Stock at $12.17

-17.58%

Aug 09/17

Aug 07/17

CxO Sell

Lew Jennifer

Sr. Vice President of Finance

M

Direct ownership

Disposed -6,600 Stock Option (Right to Buy)

-7.88%

Aug 09/17

Aug 07/17

CxO Sell

Lew Jennifer

Sr. Vice President of Finance

S

Direct ownership

Disposed -6,600 Common Stock at $12.17

-13.42%

Aug 09/17

Aug 07/17

CxO Buy

Lew Jennifer

Sr. Vice President of Finance

M

Direct ownership

Acquired 6,600 Common Stock at $0.82

15.49%

Aug 09/17

Aug 07/17

CxO Sell

Brockstedt Dirk G.

EVP of Research and Dev.

M

Direct ownership

Disposed -10,000 Stock Option (Right to Buy)

-6.09%

Aug 09/17

Aug 07/17

CxO Sell

Brockstedt Dirk G.

EVP of Research and Dev.

S

Direct ownership

Disposed -10,000 Common Stock at $12.18

-16.86%

Aug 09/17

Aug 07/17

CxO Buy

Brockstedt Dirk G.

EVP of Research and Dev.

M

Direct ownership

Acquired 10,000 Common Stock at $0.52

20.28%

Aug 09/17

Aug 07/17

CxO Sell

SCHAFER GREGORY W

Chief Operating Officer

M

Direct ownership

Disposed -12,911 Stock Option (right to buy)

-5.62%

Aug 09/17

Aug 07/17

First-Class Insider Buy

ISAACS STEPHEN T

President and CEO

M

Direct ownership

Acquired 40,000 Common Stock at $0.45

38.45%

Company: Aduro Biotech Inc.

ADRO

Stock Code:

Chart and trading summary tables represent transactions by company directors, chief executives(CEO, CFO, and senior company officers), corporate substantial shareholders, director's/executive's interest in affiliates of listed corporates, and individual substantial shareholders. Data on this page include all "Aduro Biotech Inc. (ADRO)" securities traded or transferred within the specified date range defined in stock screening and analysis panel beside the chart. (Note that, not all corporate insiders will record their trading price or number of shares bought/sold in their filings. The missing data are not included in the trading summary calculation). Different insider symbols in the price chart represent transaction activities on a particular date (Not Stock Trading Price). Additionally, transaction price in chart and trading summary table are adjusted for foreign currency exchange rate on the best efforts. The trading summary in net stock buying or stock selling totals are done on a best efforts basis. All data presented should be treated as estimates as it is based on insider trade filings which are subject to errors if input mistakes are made by a filers. Mouse over on signals to see the transaction details in the transaction info box. The chart is optimized for IE5 or above.

Disclaimer

InsidersLab.com focuses on tracking and monitoring insider trading activities in the US stocks market. "Insider Trading" means trading activities created by company directors, senior officers, individual substantial shareholders, and institutional shareholders. InsidersLab.com does not represent, warrant, nor endorse the accuracy, reliability, completeness or timeliness of any of the information, content, views, opinions, recommendations or advertisements (collectively, the "Materials") contained on, distributed through, or linked, downloaded or accessed from any of the services contained on the website (the "Service"), nor the quality of any products, information or other materials displayed, purchased, or obtained by you as a result of an advertisement or any other information or offer in or in connection with the Service (the "Products"). InsidersLab.com collects insider trading information from different public sources such as newspapers, financial information websites, and government statistics publications. You hereby acknowledge that any reliance upon any Materials shall be at your sole risk. In particular, none of the Materials is provided on the InsidersLab.com website or emails with a view to inviting, inducing or encouraging any person to make any kind of investment decision. Securities or other investments referred to in the Materials may not be suitable for you and you should not make any kind of investment decision in relation to them without first obtaining independent investment advice from a person authorized to give it.